Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2024.01.219 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Oscar Padilla und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York; Department of Radiation Oncology, Icahn School of Me…. Hauptthemen laut MEDLINE: Glioma, Microglia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
PURPOSE: Diffuse midline glioma (DMG) is a fatal tumor traditionally treated with radiation therapy (RT) and previously characterized as having a noninflammatory tumor immune microenvironment (TIME). FLASH is a novel RT technique using ultra-high dose rate that is associated with decreased toxicity and effective tumor control. However, the effect of FLASH and conventional (CONV) RT on the DMG TIME has not yet been explored. METHODS AND MATERIALS: Here, we performed single-cell RNA sequencing (scRNA-seq) and flow cytometry on immune cells isolated from an orthotopic syngeneic murine model of brainstem DMG after the use of FLASH (90 Gy/sec) or CONV (2 Gy/min) dose-rate RT and compared to unirradiated tumor (SHAM). RESULTS: At day 4 post-RT, FLASH exerted similar effects as CONV in the predominant microglial (MG) population, including the presence of two activated subtypes. However, at day 10 post-RT, we observed a significant increase in the type 1 interferon α/β receptor (IFNAR+) in MG in CONV and SHAM compared to FLASH. In the non-resident myeloid clusters of macrophages (MACs) and dendritic cells (DCs), we found increased type 1 interferon (IFN1) pathway enrichment for CONV compared to FLASH and SHAM by scRNA-seq. We observed this trend by flow cytometry at day 4 post-RT in IFNAR+ MACs and DCs, which equalized by day 10 post-RT. DMG control and murine survival were equivalent between RT dose rates. CONCLUSIONS: Our work is the first to map CONV and FLASH immune alterations of the DMG TIME with single-cell resolution. Although DMG tumor control and survival were similar between CONV and FLASH, we found that changes in immune compartments differed over time. Importantly, although both RT modalities increased IFN1, we found that the timing of this response was cell-type and dose-rate dependent. These temporal differences, particularly in the context of tumor control, warrant further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
- Department of Pediatrics, Columbia University Irving Medical Center, New York, New York; Oregon Health and Science University School of Medicine, Portland, Oregon.
- Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
- Mailman School of Public Health, Columbia University, New York, New York.
- Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.
- Department of Pediatrics, Columbia University Irving Medical Center, New York, New York; Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, New York; Department of Genetics and Developme…
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- Herbert Irving Comprehensive Cancer Center, Columbia University
- Saint Baldricks Foundation
- Hyundai Hope on Wheels
Zitieren
APA
Padilla, O., Minns, H. E., Wei, H. J., Fan, W., Webster-Carrion, A., Tazhibi, M., McQuillan, N. M., Zhang, X., Gallitto, M., Yeh, R., Zhang, Z., Hei, T. K., Szalontay, L., Pavisic, J., Tan, Y., Deoli, N., Garty, G., Garvin, J. H., Canoll, P. D., …, & Gartrell, R. D. (2024). Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.01.219
Vancouver
Padilla O, Minns HE, Wei HJ, Fan W, Webster-Carrion A, Tazhibi M, et al. Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.01.219
BibTeX
@article{Padilla2024,
author = {Padilla, Oscar and Minns, Hanna E and Wei, Hong-Jian and Fan, Weijia and Webster-Carrion, Andrea and Tazhibi, Masih and McQuillan, Nicholas M and Zhang, Xu and Gallitto, Matthew and Yeh, Rebecca and Zhang, Zhiguo and Hei, Tom K and Szalontay, Luca and Pavisic, Jovana and Tan, Yuewen and Deoli, Naresh and Garty, Guy and Garvin, James H and Canoll, Peter D and Vanpouille-Box, Claire and Menon, Vilas and Olah, Marta and Rabadan, Raul and Wu, Cheng-Chia and Gartrell, Robyn D},
title = {Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2024.01.219}
}
EUVIMED